Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Title
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 30, Issue 19, Pages 2348-2353
Publisher
American Society of Clinical Oncology (ASCO)
Online
2012-04-24
DOI
10.1200/jco.2011.36.8282

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search